Gene: SLC25A15
Official Full Name: solute carrier family 25 member 15provided by HGNC
Gene Summary: This gene is a member of the mitochondrial carrier family. The encoded protein transports ornithine across the inner mitochondrial membrane from the cytosol to the mitochondrial matrix. The protein is an essential component of the urea cycle, and functions in ammonium detoxification and biosynthesis of the amino acid arginine. Mutations in this gene result in hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome. There is a pseudogene of this locus on the Y chromosome.[provided by RefSeq, May 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO32205 | SLC25A15 Knockout cell line (HeLa) | Human | SLC25A15 | 1:3~1:6 | Negative | Online Inquiry |
KO32206 | SLC25A15 Knockout cell line (HCT 116) | Human | SLC25A15 | 1:2~1:4 | Negative | Online Inquiry |
KO32207 | SLC25A15 Knockout cell line (HEK293) | Human | SLC25A15 | 1:3~1:6 | Negative | Online Inquiry |
KO32208 | SLC25A15 Knockout cell line (A549) | Human | SLC25A15 | 1:3~1:4 | Negative | Online Inquiry |
SLC25A15 Gene Knockout Cell Lines are genetically modified cell lines developed to lack the SLC25A15 gene, which encodes the mitochondrial ornithine/citrulline transporter. These cell lines serve as pivotal tools in the study of mitochondrial function, amino acid metabolism, and cellular energy regulation. By removing the SLC25A15 gene, researchers can investigate the consequential impacts on mitochondrial homeostasis, protein synthesis, and metabolic pathways that are regulated through ornithine and citrulline transport.
The primary function of the SLC25A15 gene is to facilitate the exchange of ornithine and citrulline across the mitochondrial membrane, which is integral in the urea cycle and for synthesizing critical biomolecules such as arginine and proline. This knockout model enables scientists to explore the repercussions of its absence: alterations in metabolite levels, dysfunctions in mitochondrial processes, and implications for wider physiological outcomes in health and disease contexts.
The scientific importance of these knockout cell lines extends to various research applications, including studies related to metabolic disorders, mitochondrial diseases, and potential therapeutic interventions targeting metabolic pathways. In clinical settings, understanding the dynamics of amino acid transport can contribute to developing therapies for conditions like hyperammonemia, where the urea cycle is compromised.
Compared to conventional wild-type cell lines, SLC25A15 knockout cell lines provide a specialized model that allows for precise genetic analysis and a clearer understanding of metabolic pathways. Researchers favor these knockout lines due to their ability to illuminate the roles of specific genes in pathophysiological conditions, ultimately yielding insights that can guide drug development and metabolic engineering.
Investing in SLC25A15 Gene Knockout Cell Lines supports researchers and clinicians in advancing metabolic research, offering unparalleled insights into mitochondrial biology and amino acid homeostasis. Our company specializes in providing high-quality genetic models tailored to the needs of the scientific community, backed by extensive expertise in genetic engineering and a commitment to facilitating groundbreaking research contributions.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.